Download PDF
Synthesis 1997; 1997(6): 625-627
DOI: 10.1055/s-1997-1398
short paper
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Facile and Efficient Synthesis of 7,10-Dihydroxy-6H-pyrazolo[4,5,1-de]acridin-6-one via Hypervalent Iodine Oxidation

Nobuyuki Kato* , Toru Sugaya, Takashi Mimura, Masanori Ikuta, Sachiko Kato, Yukihiro Kuge, Shinji Tomioka, Masaji Kasai
  • *Sakai Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 1-1-53 Takasucho, Sakai, Osaka 590, Japan, Fax +81(722)277214
Further Information

Publication History

Publication Date:
31 December 2000 (online)

  PDF Download  Permissions and Reprints All articles of this category

An improved synthetic procedure for 5,8-dibromo-7,10-dihydroxy-2-methyl-6H-pyrazolo[4,5,1-de]acridin-6-one (4), an intermediate of a novel class of antitumor agents, was developed. An effective introduction of a hydroxy group to the C10 of 5,8-dibromo-7-hydroxy-2-methyl-6H-pyrazolo[4,5,1-de]acridin-6-one (2b) was accomplished in two steps via the oxidation of 2b to the corresponding quinone using hypervalent iodine reagent in an acidic medium, followed by reduction of the resulting quinone upon treatment with aqueous sodium hydrosulfite.

pyrazoloacridine derivative - hypervalent iodine oxidation - quinone intermediate of antitumor agent - fused heterocyclic compound